Mechanism on disorders of coagulation and fibrinolysis in diabetes

Diabetes

Volumn 45, Issue 3 SUPPL., 1996, Pages

  Matsuda, Tamotsu ^a,b   Morishita, Eriko ^a   Jokaji, Hiroshi ^a   Asakura, Hidesaku ^a   Saito, Masanori ^a   Yoshida, Tomotaka ^a   Takemoto, Ken Ichi ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRIN; FIBRINOGEN; LIPOPROTEIN A; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; THROMBIN; THROMBOCYTE FACTOR 4; THROMBOPLASTIN; THROMBOXANE;

BRAIN INFARCTION; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOSIS;

BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FIBRINOLYSIS; HUMANS;

EID: 0029886247     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.3.s109     Document Type: Article

References (12)

1. di Minno G, Silver MJ, Cerbone AM, Riccardi G, Rivellese A, Mancini M, Thiagarajan P: Increased binding of fibrinogen to platelets in diabetes; the role of prostaglandins and thromboxane. Blood 65:156-162, 1985
2. Garcia F, de la Calle H, Alava I, Navarro JL, Creighton LJ, Gaffney PJ: Diabetes mellitus as a hypercoagulable state; its relationship with fibrin fragments and vascular damage. Thromb Res 47:533-540, 1987
3. Cho NH, Decker D, Dorman JS, Wolfson LF, Kuller LH, Drash AL, Follansbee WF, Kelsey SF, Orchard TJ: Spontaneous whole blood platelet aggregation in insulin-dependent diabetes mellitus; an evaluation in an epidemiologic study. Thromb Haemostasis 61:127-130, 1989
4. Shukla SD, Paul A, Klachko DM: Hypersensitivity of diabetic human platelets to platelet activating factor. Thromb Res 66:239-246, 1992
5. Malyszko J, Urano T, Knofler R, Taminato A, Yoshimi T, Tanaka Y, Takada A: Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes. Thromb Res 75:569-586, 1994
6. Christe M, Fritschi J, Lämmle B, Tran TH, Marbet GA, Berger W, Duckert F: Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy. Thromb Haemostasis 52:138-143, 1984
7. v. d. Knaap JH, de Boer AC, Pannebakker MAG, van Heerde W, den Ottolander GJH: The effect of diabetes regulation on platelet release, fibrinolysis and coagulation tests, before and after stimulation with DDAVP. Thromb Haemostasis 53:118-125, 1985
8. Landgraf-Leurs MMC, Ladik T, Smolka B, Bock T, Schramm W, Spannagl M, Landgraf R: Increased thromboplastic potential in diabetes; a multifactorial phenomenon. Klin Wochenschr 65:600-606, 1987
9. Miller ME, Anagnostou AA, Ley B, Marshall P, Steiner M: Effect of fish oil concentrates on hemorheological and hemostatic aspects of diabetes mellitus; a preliminary study. Thromb Res 47:201-214, 1987
10. Sacchi S, Curci G, Piccinini L, Messerotti A, Roncaia R, Bendetti PG: Platelet a granule release in diabetes mellitus. Scand J Clin Lab Invest 45:165-168, 1985
11. Rosove MH, Frank HJL, Harwig SSL, Berliner J: Plasma β- thromboglobulin is correlated with platelet adhesiveness to bovine endothelium in patients with diabetes mellitus. Thromb Res 37:251-258, 1985
12. di Mario U, Borsey DQ, Contreas G, Prowse CV, Clarke BF, Andreani D: The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type diabetic patients with and without proliferative retinopathy. Clin Exp Immunol 65:57-68, 1986